Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed later-stage tilt small index

Childhood Idiopathic Nephrotic Syndrome: later-stage trial registry

A small indexed set (1 trial) with no open enrollment listed right now.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · none currently recruiting · #11,370 of 28,707 conditions by registered trial count

Childhood Idiopathic Nephrotic Syndrome: 1 US clinical trial tracked, none currently recruiting.

Childhood Idiopathic Nephrotic Syndrome is the subject of 1 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is Hoffmann-La Roche, running 1 of these trials.

Enrollment posture brief

Registry condition childhood-idiopathic-nephrotic-syndrome

OPEN 0 | RECR 0% | LATE 1 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Childhood Idiopathic Nep (this)Childhood Idiopathic Nep (th…0%
Open-enrollment share among volume-matched conditions near Childhood Idiopathic Nephrotic Syndrome

Childhood Idiopathic Nephrotic Syndrome has no open enrollment in this registry pull (1 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Childhood Idiopathic Nephrotic Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Childhood Idiopathic Nephrotic Syndrome is recruiting below its size-band peers.

    0 of 1 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Top Sponsors

Named interventions

Most-linked intervention names on Childhood Idiopathic Nephrotic Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Acetaminophen/ Paracetamol Drug
1 trials
MMF Drug
1 trials
Methylprednisolone Drug
1 trials
Prednisone Drug
1 trials
Obinutuzumab Drug
1 trials

US sites by state

Facility locations filed on Childhood Idiopathic Nephrotic Syndrome trials. A trial with sites in several states counts in each.

Virginia 1 trials
Utah 1 trials
New Jersey 1 trials
North Carolina 1 trials
Georgia 1 trials
Florida 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Childhood Idiopathic Nephrotic Syndrome page

1 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Childhood Idiopathic Nephrotic Syndrome trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Hoffmann-La Roche sponsors the most Childhood Idiopathic Nephrotic Syndrome trials on record, review their full trial history before evaluating a specific study. See Hoffmann-La Roche's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Childhood Idiopathic Nephrotic Syndrome condition card totals 1 registered trials; most-linked intervention Acetaminophen/ Paracetamol; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.